Kubben et al. showed that progerin interferes with Nrf2 function and that genetic or pharmacological activation of Nrf2 can reverse several of the cell‐aging phenotypes associated with HGPS (Kubben et al., 2016). Here, LMNA is linked to Hutchinson-Gilford progeria syndrome.